Erlocip 100mg Tablet contains Erlotinib, a selective oral tyrosine kinase inhibitor that targets the epidermal growth factor receptor (EGFR). This medication is primarily prescribed for patients with advanced non-small cell lung cancer (NSCLC) and pancreatic cancer. By blocking EGFR signaling, Erlotinib disrupts cancer cell proliferation, making it a vital component of modern cancer therapy.
Key Features:
Orders ship from our India Head Office within 1–2 business days of confirmation. We include full customs documentation — HS codes, certificates of origin, and pharmaceutical export permits.
Estimated delivery: 3–7 business days to UK. 7–10 business days to UAE, Saudi Arabia and Gulf countries. 10–15 days for USA and Asian countries.
All packages arrive in plain, unmarked brown boxes. No pharmacy name or medication details on the outside.
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.